Ostomy & IBD, plainly
Sourced explainers — slower and cited, not breaking news.
Could GLP-1 drugs help with a high-output stoma? What a 2026 review actually found
GLP-1 receptor agonists — the drug class behind weight-loss headlines — are being looked at for high-output stomas. A 2026 scoping review says the early signal is interesting but the evidence is still thin.
Read explainer →Latest
Sourced explainerCould GLP-1 drugs help with a high-output stoma? What a 2026 review actually found
GLP-1 receptor agonists — the drug class behind weight-loss headlines — are being looked at for high-output stomas. A 2026 scoping review says the early signal is interesting but the evidence is still thin.
Ostomy complications, grouped: what a 2026 clinical review lists — and why it points to your care team
A 2026 clinical review catalogues the known ostomy complications into earlier and later ones. It's a map of what exists, not a checklist for self-diagnosis — and that distinction matters.
Beyond bacteria: why researchers are now looking at gut viruses and fungi in IBD
A 2026 review argues the gut's viruses and fungi have been comparatively overlooked in inflammatory bowel disease. Here's what that does — and does not — mean for patients.
Practical living
Sourced explainerNutrition
Sourced explainerWe share these on Instagram
There is no newsletter or sign-up here. New explainers and short summaries go out on Instagram — follow along there if you'd like updates.
Follow @ostomyfan →